maxkozlov.com
signal: mkozlov.01
That's because crucial NIH grant-review panels are slated to be empty at those institutes by Jan 2027.
A wonky bureaucratic problem with big implications.
A short 🧵
The directive is the start of a broader shake-up at NIAID, which has long been attacked by Republicans.
The directive is the start of a broader shake-up at NIAID, which has long been attacked by Republicans.
The directive is the start of a broader shake-up at NIAID, which has long been attacked by Republicans.
The directive is the start of a broader shake-up at NIAID, which has long been attacked by Republicans.
Cc. @maxkozlov.bsky.social.
Cc. @maxkozlov.bsky.social.
Make it make sense.
Scoop from @maxkozlov.bsky.social @nature.com www.nature.com/articles/d41...
Make it make sense.
Scoop from @maxkozlov.bsky.social @nature.com www.nature.com/articles/d41...
The directive is the start of a broader shake-up at NIAID, which has long been attacked by Republicans.
The directive is the start of a broader shake-up at NIAID, which has long been attacked by Republicans.
Preliminary data indicate that these tools are linked with a slightly higher funding rate and might be pulling the focus of research towards safe, less-innovative ideas.
Preliminary data indicate that these tools are linked with a slightly higher funding rate and might be pulling the focus of research towards safe, less-innovative ideas.
Preliminary data indicate that these tools are linked with a slightly higher funding rate and might be pulling the focus of research towards safe, less-innovative ideas.
Preliminary data indicate that these tools are linked with a slightly higher funding rate and might be pulling the focus of research towards safe, less-innovative ideas.
That leaves a whopping 15 of 27 institutes and centers without a permanent director.
That leaves a whopping 15 of 27 institutes and centers without a permanent director.
By @lizziegibney.bsky.social and me
By @lizziegibney.bsky.social and me
My reporting:
My reporting:
Under the current EOs this is seen as an illegal preference. The administration’s argument is that choosing someone based on their demographic instead of their skills violates civil rights laws.
Under the current EOs this is seen as an illegal preference. The administration’s argument is that choosing someone based on their demographic instead of their skills violates civil rights laws.
Read the full ruling below.
Read the full ruling below.
NIAID's council is set to run out of voting members in October. No grants can be funded without Council.
BALDWIN: This poses a very serious threat to NIH's ability to fund research.
BHATTACHARYA: I've ordered the ICs to nominate new members... including for the advisory committee to the director [which hasn't met since Dec 2024]
NIAID's council is set to run out of voting members in October. No grants can be funded without Council.
But they're preventable! And treatable! And eliminatable!
But they're preventable! And treatable! And eliminatable!
Can you explain why schools on the coast seem to get more NIH funding than schools like my state, which is doing a lot of research as well?
Thankfully I haven't been escorted out of this event (yet). Here's what I'm following. You can also watch live here:
www.help.senate.gov/hearings/mod...
Thankfully I haven't been escorted out of this event (yet). Here's what I'm following. You can also watch live here:
www.help.senate.gov/hearings/mod...
Bhattacharya: I do not believe the measles vaccine causes autism.
Sanders: I didn't ask about measles. Do vaccines cause autism?
Bhattacharya: I have not seen a study to suggest any **single** vaccine causes autism.
(emphasis mine)
www.help.senate.gov/hearings/mod...
Bhattacharya: I do not believe the measles vaccine causes autism.
Sanders: I didn't ask about measles. Do vaccines cause autism?
Bhattacharya: I have not seen a study to suggest any **single** vaccine causes autism.
(emphasis mine)
Memoli says NIH was 3 years behind in filling slots when he came in (but neglects to say NIH disinvited dozens of people about to join them).
"Better late than never?" the source says.
That's because crucial NIH grant-review panels are slated to be empty at those institutes by Jan 2027.
A wonky bureaucratic problem with big implications.
A short 🧵
Memoli says NIH was 3 years behind in filling slots when he came in (but neglects to say NIH disinvited dozens of people about to join them).
@jocelynkaiser.bsky.social and I registered for the event months ago yet were told capacity was full, even as they let in dozens of others.
@jocelynkaiser.bsky.social and I registered for the event months ago yet were told capacity was full, even as they let in dozens of others.
@jocelynkaiser.bsky.social and I registered for the event months ago yet were told capacity was full, even as they let in dozens of others.
Our year in numbers begs to differ
www.nature.com/immersive/d4...
Our year in numbers begs to differ
www.nature.com/immersive/d4...
"Better late than never?" the source says.
That's because crucial NIH grant-review panels are slated to be empty at those institutes by Jan 2027.
A wonky bureaucratic problem with big implications.
A short 🧵
"Better late than never?" the source says.
That's because crucial NIH grant-review panels are slated to be empty at those institutes by Jan 2027.
A wonky bureaucratic problem with big implications.
A short 🧵
That's because crucial NIH grant-review panels are slated to be empty at those institutes by Jan 2027.
A wonky bureaucratic problem with big implications.
A short 🧵